Flore Poloni

I am a partner in the dispute resolution group in Paris, with extensive experience advising companies and public entities on complex cross-border disputes.

My work focuses on complex arbitration proceedings across strategic sectors such as energy, defence, life sciences and logistics, often linked to projects in Africa. I act as counsel in significant international cases and also serve as an arbitrator, offering clients a well-rounded perspective on dispute resolution.

I have extensive experience in high-stakes arbitrations arising from commercial agreements, corporate transactions, and shareholder arrangements. Many of these cases involve sensitive issues triggered by geopolitical or regulatory changes, including sanctions and force majeure events. Clients value my ability to manage time-critical proceedings and deliver practical solutions that protect their interests.

With a background spanning business and law and in-house experience in claims management, I bring a commercially focused approach to arbitration strategy. Also having a litigation background, I also advise on enforcement and asset recovery to ensure that awards translate into tangible results. I am also experienced at handling parallel proceedings of all kinds and in all jurisdictions.

Beyond my practice, I am committed to shaping the future of arbitration. I co-founded the Paris Very Young Arbitration Practitioners and co-chair the LCIA-YIAG (Young International Arbitration Group of the London Court of International Arbitration). Both of which promote diversity and inclusion for younger practitioners and have led international forums to encourage best practices for the proceedings of tomorrow.

• Representing a pharmaceutical company in ICC arbitration proceedings against a business partner in relation to a dispute concerning the purported termination of a research and development partnership between the parties. The matter is a 'bet-the-company' dispute of particularly high value and represents a dispute between top players in the pharmaceutical industry.
• Representing a Japanese pharmaceuticals company in a dispute originating from the potential violation of a non-compete agreement.
• Advising a mining company in relation to insurance claims made under a Terrorism and Sabotage Policy following an attack on a facility by pro-independence groups. This was a highly sensitive matter given the political context. The matter was valued at USD 100 million.
• Representing a French leading company in the food and beverage sector in an ICC arbitration relating to a distribution dispute. Initially stemming from the non-renewal of a distribution agreement entered into between the French company and its Lebanese business partner, these arbitration proceedings have taken on a high level of complexity
• Representing a logistics company in an ICC arbitration relating to a tax issue in Mauritania.
• Representing a private equity fund in ICC arbitration in the context of a shareholder dispute following the sale of its shares in a French media company.